NEW YORK, Dec 21 - Incyte Genomics will acquire Proteome in a $77 million cash and equity deal as part of its plans to create the first fully annotated human proteome and beef up annotations on its genomic databases, Incyte CEO Roy Whitfield said Thursday.

" There isn’t anybody who can touch Proteome in terms of annotation," Whitfield told GenomeWeb. " First thing, Proteome will annotate all the unique full length genes we have discovered through our relationship with Pfizer."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.